Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Enzo Biochem reports positive phase II data for hepatitis B treatment

Oct. 17, 2001

Hollis-Eden cleared to begin HE-2000 trial for hepatitis B

Oct. 16, 2001

High-dose ISIS-2302 enemas improve symptoms in ulcerative colitis

Oct. 15, 2001

Gene therapy with IL-10 produces therapeutic benefit in experimental colitis

Oct. 15, 2001

Inhibition of p38 MAPK in experimental model of colitis has dual effect

Oct. 15, 2001

Efficacy of MAP kinase blocker CNI-1493 in Crohn's disease seen in pilot trial

Oct. 15, 2001

Roche's PEGASYS introduced in first market

Oct. 15, 2001

Clinically used pain medication now claimed for IBS

Oct. 11, 2001

Phase II trial of Heptazyme for hepatitis C initiated

Oct. 11, 2001

New triple therapy for H. pylori eradication submitted for approval on two fronts

Oct. 9, 2001

Popular Stories

Today's news in brief
BioWorld
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...